Back to results
US 2025/0152584 A1Published application
Nlrp3 inflammasome inhibitor and uses thereof
AssigneeTransthera Sciences (Nanjing), Inc.
InventorsLin Li, Frank Wu
Life of this patent
Estimating the term…
Abstract
The present application belongs to the technical field of medicines, relates to an NLRP3 inflammasome inhibitor and the uses thereof, and particularly relates to a compound represented by general formula (A) or a pharmaceutically acceptable salt, a stereoisomer and a tautomer thereof. The inhibitor has biological activity on NLRP3 inflammasome, and has important clinical development value for treatment of NLRP3-related diseases.
Claims20
A compound of general formula (A) or a pharmacologically acceptable salt, stereoisomer or tautomer thereof:
- Y—W—R3 (A)
- wherein,
- W is selected from
- X1 and X2 are each independently selected from C or N;
- R1 is selected from hydrogen, hydroxyl, amino, carboxyl, cyano, nitro, halogen, carbonyl, C1-6 alkyl, halo C1-6alkyl, C1-6 alkoxy, halo C1-6 alkoxy, C2-6 alkenyl, C2-6 alkynyl, 3-7 membered heterocyclyl, 3-7 membered cycloalkyl, aryl, 5-7 membered heteroaryl, —N(C1-6 alkyl)2, —S—C1-6 alkyl, or absent;
- R2 is selected from hydrogen, hydroxyl, amino, carboxyl, cyano, nitro, halogen, carbonyl, C1-6 alkyl, halo C1-6alkyl, C1-6 alkoxy, C1-6 haloalkoxy, C2-6 alkenyl, C2-6 alkynyl, 3-7 membered heterocyclyl, 3-7 membered cycloalkyl, aryl, 5-7 membered heteroaryl, —N(C1-6 alkyl)2, —S—C1-6 alkyl, or absent;
- R1 and R2 are each optionally substituted by 1-3 substituents selected from hydroxyl, amino, carboxyl, cyano, nitro, halogen, carbonyl, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, 3-7 membered heterocyclyl, 3-7 membered cycloalkyl, aryl, and 5-7 membered heteroaryl;
- or
- R1 and R2, together with the carbon or nitrogen atom to which they are attached, form a 5-12 membered ring A, the 5-12 membered ring A is optionally substituted by 1-4 substituents selected from the group consisting of hydroxyl, amino, carboxyl, cyano, nitro, halogen, carbonyl, C1-6 alkyl, —NH—C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, 3-7 membered heterocyclyl, 3-7 membered cycloalkyl, aryl, 5-7 membered heteroaryl, C1-6 alkylsulfonyl, and —N(C1-6 alkyl)2;
- R3 is selected from the group consisting of —(C1-6 alkylene)0-2-NR4R5, —(C1-6 alkylene)0-2-NR4—COR5, —(C1-6 alkylene)0-2-CO—NR4—R5, and —(C1-6 alkylene)0-2-NR4—C1-6 alkylene-R5;
- R4 is selected from hydrogen or C1-6 alkyl;
- R5 is selected from the group consisting of 3-7 membered heterocyclyl, 3-7 membered cycloalkyl, aryl, and 5-7 membered heteroaryl;
- R5 is optionally substituted by 1-4 substituents selected from the group consisting of halogen, cyano, amino, hydroxyl, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, 3-7 membered heterocyclyl, 3-7 membered cycloalkyl, aryl, 5-7 membered heteroaryl, C2-6 alkenylcarbonyl, sulfonyl, and C1-6 alkylcarbonyl;
- when R5 is substituted, the substituent on R5, which is C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, 3-7 membered heterocyclyl, 3-7 membered cycloalkyl, aryl, 5-7 membered heteroaryl, or sulfonyl, is optionally substituted by 1-3 substituents selected from the group consisting of halogen, cyano, amino, hydroxy, carbonyl, C1-6 alkyl, 3-6 membered cycloalkyl, 3-6 membered heterocyclyl, carboxyl, and C1-6 alkylsulfonyl;
- Y is selected from the group consisting of aryl, 5-14 membered heteroaryl, 3-14 membered heterocyclyl, and 3-12 membered cycloalkyl;
- (1) when X1 and X2 are each selected from C,
- Y is substituted by C2-6 alkenyl or C2-6 alkynyl, and is optionally substituted by 1-2 substituents selected from the group consisting of halogen, cyano, amino, hydroxy, carbonyl, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, 3-7 membered heterocyclyl, 3-7 membered cycloalkyl, aryl, 5-7 membered heteroaryl, C1-6 alkylamino, C1-6 alkylcarbonylamino, C1-6 alkylsulfonyl, aminocarbonyl, C1-6 alkylaminocarbonyl, and sulfonyl;
- (2) when either one or two of X1 and X2 is/are selected from N,
- Y is optionally substituted by 1-3 substituents selected from the group consisting of C2-6 alkenyl, C2-6 alkynyl, halogen, cyano, amino, hydroxy, carbonyl, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, 3-7 membered heterocyclyl, 3-7 membered cycloalkyl, aryl, 5-7 membered heteroaryl, C1-6 alkylamino, C1-6 alkylcarbonylamino, C1-6 alkylsulfonyl, aminocarbonyl, C1-6 alkylaminocarbonyl, sulfonyl, —N(C1-6 alkyl)2, and —S—C1-6 alkyl;
- in (1) and (2) above, when Y is substituted,
- the substituent on Y, which is C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, 3-7 membered heterocyclyl, 3-7 membered cycloalkyl, aryl, 5-7 membered heteroaryl, or sulfonyl, is optionally substituted by 1-3 substituents selected from the group consisting of halogen, cyano, amino, hydroxy, carbonyl, C1-6 alkyl, and 3-6 membered cycloalkyl;
- or
- the substituent on Y, which is C2-6 alkenyl or C2-6 alkynyl, is optionally substituted by 1-3 substituents selected from the group consisting of halogen, cyano, amino, hydroxy, carbonyl, unsubstituted or hydroxy-substituted C1-6 alkyl, unsubstituted or hydroxy-substituted 3-6 membered cycloalkyl, and C1-6 haloalkyl.
20 more elements
Dependencies are inferred from the claim text.